Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Abstract Background No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear. This meta-analysis...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng
Formato:	Artigo
Idioma:	English
Publicado em:	BMC 2017-12-01
coleção:	BMC Cancer
Assuntos:	Hepatic resection Transarterial chemoembolization Hepatocellular carcinoma Portal vein tumor thrombus
Acesso em linha:	http://link.springer.com/article/10.1186/s12885-017-3895-z

Registros relacionados

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv WF, et al.
Publicado em: (2018-10-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
por: Junwei Chen, et al.
Publicado em: (2023-07-01)

Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
por: Ran You, et al.
Publicado em: (2024-09-01)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
por: Danbi Lee, et al.
Publicado em: (2018-06-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
por: Won-Gyom Choe, et al.
Publicado em: (2018-01-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
por: Yashwant Patidar, et al.
Publicado em: (2021-04-01)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
por: Xiaomi Li, et al.
Publicado em: (2023-08-01)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
por: Fangzhou Luo, et al.
Publicado em: (2021-09-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
por: Fei-Xiang Wu, et al.
Publicado em: (2017-09-01)

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
por: Zi-Han Zhang, et al.
Publicado em: (2023-01-01)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
por: Ling Li, et al.
Publicado em: (2022-02-01)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
por: Jin-Kai Feng, et al.
Publicado em: (2022-11-01)

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
por: Xia WL, et al.
Publicado em: (2024-09-01)

Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus
por: Yu Zhang, et al.
Publicado em: (2022-01-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Moon Haeng Hur, et al.
Publicado em: (2023-07-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
por: Aoran Dong, et al.
Publicado em: (2023-12-01)

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
por: Li SQ, et al.
Publicado em: (2023-10-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Thrombosis: A Perspective on Survival
por: Yadav Ajit, et al.
Publicado em: (2014-11-01)

Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant
por: Tai-Wei Ye, et al.
Publicado em: (2024-08-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
por: Xiao-Hui Zhao, et al.
Publicado em: (2022-10-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
por: Su Jong Yu, et al.
Publicado em: (2023-03-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
por: Jia Deng, et al.
Publicado em: (2023-01-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
por: Huang Q, et al.
Publicado em: (2020-09-01)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
por: Junwei Chen, et al.
Publicado em: (2022-11-01)

Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
por: Saikang Tang, et al.
Publicado em: (2024-07-01)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
por: Jiwon Yang, et al.
Publicado em: (2024-09-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
por: You-Bin Wang, et al.
Publicado em: (2023-09-01)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
por: Zhao XH, et al.
Publicado em: (2023-02-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Shuling Chen, et al.
Publicado em: (2019-04-01)

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
por: Jin Hyoung Kim, et al.
Publicado em: (2024-10-01)

A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Young Keun Sur, et al.
Publicado em: (2015-01-01)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
por: Hiroki Higashihara, et al.
Publicado em: (2021-10-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
por: Al Fuhaid Turki, et al.
Publicado em: (2007-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
por: Zhang W, et al.
Publicado em: (2021-07-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Mahmoud Abu Elfadl, et al.
Publicado em: (2019-01-01)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
por: Xiaodong Song, et al.
Publicado em: (2020-08-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
por: B. I. Dolgushin, et al.
Publicado em: (2016-09-01)

Transileocolic Vein Obliteration for Bleeding Rectal Varices with Portal Thrombus
por: Hirotaka Arai, et al.
Publicado em: (2013-03-01)

A combination of portal vein stent insertion and endovascular iodine-125 seed-strip implantation, followed by transcatheter arterial chemoembolization with sorafenib for treatment of hepatocellular carcinoma-associated portal vein tumor thrombus
por: Shuangxi Li, et al.
Publicado em: (2021-12-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
por: Zheng Y, et al.
Publicado em: (2024-06-01)